A Phase I Study of SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGF-b, in Patients with Advanced Nonsmall Cell Lung Cancer (NSCLC)
ANNALS OF ONCOLOGY(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined